IP Library Assignment 050152/0828
Patent Assignment
Reel/Frame 050152/0828

Grant of Security Interest in Patents

Recorded: 2019-03-20 Pages: 10
Assignors
EGALET CORPORATION
Executed: 2019-03-20
EGALET US, INC.
Executed: 2019-03-20
EGALET LIMITED
Executed: 2019-03-20
Assignee
CANTOR FITZGERALD SECURITIES, AS COLLATERAL AGENT
110 E. 59TH STREET, NEW YORK, NEW YORK, 10022
Covered Properties (25)
Controlled Release Composition
Patent: 6,787,156 →
Application: 08/693,254 →
Morphine controlled release system
Patent: 8,877,241 →
Application: 10/550,453 →
Publication: US 2007/0003617
Matrix Compositions for Controlled Delivery of Drug Substances
Patent: 8,298,581 →
Application: 10/550,685 →
Publication: US 2007/0042044
Swellable Dosage Form Comprising Gellan Gum
Patent: 8,383,154 →
Application: 11/596,123 →
Publication: US 2008/0299199
Solid Pharmaceutical Composition with a First Fraction of a Dispersion Medium and a Second Fraction of a Matrix, the Latter Being at Least Partially First Exposed to Gastrointestinal Fluids
Application: 11/915,655 →
Publication: US 2009/0274759
Polymer release system
Patent: 8,617,605 →
Application: 12/073,692 →
Publication: US 2008/0254122
Controlled release carvedilol compositions
Patent: 8,449,914 →
Application: 12/076,105 →
Publication: US 2008/0268057
Morphine Polymer Release System
Patent: 8,609,143 →
Application: 12/078,312 →
Publication: US 2008/0254123
Controlled Release Pharmaceutical Compositions for Prolonged Effect
Patent: 8,821,928 →
Application: 12/602,953 →
Publication: US 2010/0239667
Immediate Release Composition Resistant to Abuse by Intake of Alcohol
Patent: 9,005,660 →
Application: 12/701,248 →
Publication: US 2010/0204259
Pharmaceutical Compositions Resistant to Abuse
Patent: 8,603,526 →
Application: 12/701,429 →
Publication: US 2010/0203130
Formulations and Methods for the Controlled Release of Active Drug Substances
Patent: 8,563,038 →
Application: 12/823,067 →
Publication: US 2011/0159100
Swellable Dosage Form Comprising Gellan Gum
Patent: 8,383,155 →
Application: 13/212,679 →
Publication: US 2012/0039969
Formulations and Methods for the Controlled Release of Active Drug Substances
Patent: 9,023,394 →
Application: 13/928,135 →
Publication: US 2013/0287849
Abuse Deterrent Pharmaceutical Compositions for Controlled Release
Patent: 9,549,899 →
Application: 13/933,053 →
Publication: US 2014/0010873
Morphine Polymer Release System
Patent: 8,808,745 →
Application: 13/974,346 →
Publication: US 2014/0093569
Polymer Release System
Patent: 9,694,080 →
Application: 13/974,689 →
Publication: US 2014/0120164
Pharmaceutical Compositions Resistant to Abuse
Patent: 9,168,228 →
Application: 14/062,719 →
Publication: US 2014/0050787
Abuse-Deterrent Pharmaceutical Compositions for Controlled Release
Patent: 9,044,402 →
Application: 14/249,965 →
Publication: US 2014/0220126
Opioid Polymer Release System
Patent: 9,707,179 →
Application: 14/331,833 →
Publication: US 2015/0037417
Immediate Release Composition Resistant to Abuse by Intake of Alcohol
Patent: 9,358,295 →
Application: 14/656,016 →
Publication: US 2015/0313997
Pharmaceutical Compositions Resistant to Abuse
Patent: 9,498,446 →
Application: 14/859,800 →
Publication: US 2016/0074332
Pharmaceutical Compositions Resistant to Abuse
Application: 15/293,867 →
Publication: US 2017/0100341
Hearing Device System with a Voice Communication Device, and Method of Operating the System
Application: 15/373,002 →
Publication: US 2017/0164123
Pharmaceutical Tablet
Patent: 640,366 →
Application: 29/367,466 →
Related Assignments (14)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest May 4, 2012
From: ANDERSEN, CHRISTINE; FISCHER, GINA; BAR-SHALOM, DANIEL; SLOT, LILLIAN
To: EGALET A/S
Reel/Frame 028160/0735 →
Assignment of Assignor's Interest Oct 18, 2013
From: TYGESEN, PETER HOLM; LINDHARDT, KARSTEN; OLSEN, MARTIN REX; FISCHER, GINA ENGSLEV
To: EGALET LTD.
Reel/Frame 031438/0724 →
Assignment of Assignor's Interest Nov 5, 2013
From: EGALET A/S
To: EGALET LTD.
Reel/Frame 031544/0552 →
Assignment of Assignor's Interest Nov 5, 2013
From: ANDERSEN, CHRISTINE; LINDHARDT, KARSTEN; OEVERGAARD, JAN MARTIN; LYHNE-IVERSEN, LOUISE INOKA
To: EGALET A/S
Reel/Frame 031544/0370 →
Security Interest Aug 31, 2016
From: EGALET CORPORATION; EGALET US, INC.; EGALET LTD
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 039600/0791 →
Corrective Assignment to Correct the Omitted Inventor Previously Recorded at Reel: 019693 Frame: 0031. Assignor(S) Hereby Confirms the Assignment. Sep 16, 2016
From: BAR-SHALOM, DANIEL; SLOT, LILLIAN; FISCHER, GINA; HEMMINGSEN, PERNILLE HOYRUP
To: EGALET A/S
Reel/Frame 040054/0790 →
Change of Address Oct 3, 2016
From: EGALET LTD.
To: EGALET LTD.
Reel/Frame 040293/0249 →
Release of Security Interest Apr 12, 2019
From: CANTOR FITZGERALD SECURITIES, AS AGENT AND AS COLLATERAL AGENT
To: EGALET CORPORATION; EGALET LIMITED; EGALET US, INC.
Reel/Frame 048869/0749 →
Assignment of Assignor's Interest Jun 18, 2019
From: EGALET LTD
To: ADARE PHARMACEUTICALS, INC.
Reel/Frame 049505/0851 →
Release of Security Interest Sep 13, 2019
From: U.S. BANK NATIONAL ASSOCIATION
To: EGALET CORPORATION; EGALET US, INC.; EGALET LTD
Reel/Frame 050367/0019 →
Release of Security Interest in Patents May 21, 2020
From: CANTOR FITZGERALD SECURITIES, AS AGENT AND AS COLLATERAL AGENT
To: ZYLA LIFE SCIENCES (F/K/A EGALET CORPORATION); ZYLA LIFE SCIENCES US INC. (F/K/A EGALET US, INC.); EGALET LIMITED
Reel/Frame 052740/0025 →
Release of Security Interest Aug 5, 2020
From: U.S. BANK NATIONAL ASSOCIATION
To: ZYLA LIFE SCIENCES, F/K/A EGALET CORPORATION; ZYLA LIFE SCIENCES US INC., F/K/A EGALET US, INC.; EGALET LIMITED
Reel/Frame 053411/0496 →
Security Interest Sep 22, 2020
From: ADARE PHARMACEUTICALS, INC.; ADARE PHARMACEUTICALS USA, INC.
To: CRESCENT AGENCY SERVICES LLC, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT
Reel/Frame 053849/0967 →
Security Interest Nov 8, 2022
From: ADARE PHARMACEUTICALS, INC.; ADARE PHARMACEUTICALS USA, INC.
To: TEAL MIDCO HOLDINGS, L.P.
Reel/Frame 061698/0541 →